Standout Papers

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete resp... 2022 2026 2023 2024126
  1. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response (2022)
    Sibylle Loibl, Andreas Schneeweiß et al. Annals of Oncology

Immediate Impact

64 standout
Sub-graph 1 of 21

Citing Papers

NLRC5 senses NAD+ depletion, forming a PANoptosome and driving PANoptosis and inflammation
2024 Standout
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
2024 Standout
1 intermediate paper

Works of Julia Rey being referenced

Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases
2020
Prevalence of Anemia in Inflammatory Bowel Diseases in European Countries
2014

Author Peers

Author Last Decade Papers Cites
Julia Rey 346 151 119 35 822
Konstantinos Papadimitriou 334 91 119 47 685
David Mizrahi 522 97 29 41 824
Masashi Mikami 138 163 51 57 716
Rachel Conyers 315 244 91 49 860
Stephen Kelly 115 92 112 36 958
Noboru Kobayashi 86 199 22 71 877
David W. Ellis 179 136 45 43 756
Li-Sheng Chen 300 170 81 34 830
Minkyung Han 80 81 26 64 806
Mary Woods 334 115 61 39 983

All Works

Loading papers...

Rankless by CCL
2026